Location of Repository

Studies into the Efficacy of Using Non-Purified Islets for Clinical Islet Transplantation

By M’Balu Alena Webb


Islet purification prior to allo transplantation currently forms the clinical gold standard, despite the fact that purification protocols result in significant islet losses and remove potential islet precursors and tissue that may provide islets with bio-trophic support Conversely, non-purified islet preparations retain endocrine mass and within the sphere of islet auto transplantation have been associated with excellent long-term graft function.\ud This study comprises of an analysis of peri-operative factors and the long-term graft function of patients’ auto transplanted with either purified (n=14) or nonpurified islets (n=23). Complementary in-vitro studies were carried out to assess the effect of non-islet tissue on islet viability, integrity and function (n=8), whilst a histology-based study (n=23) assessed whether transplantation of non-islet cells, particularly islet precursors, had a long-term effect on graft function in the clinical setting.\ud Clinically, non-purified islets did not significantly increase peri-transplant venous pressures and perioperative factors including ITU stay, blood loss and liver function were comparable in both groups. Analysis of the 5 year post-transplant period demonstrated that although insulin release in response to glucose was initially superior following transplant of purified islets, non-purified islets were associated with stable long-term function. In-vitro studies reiterated these findings, revealing that islet viability and function were comparable in both groups, however, retention of intracellular insulin was found to be superior within non-purified preparations with some evidence that ductal tissue provided islets with bio-trophic support. Histology-based analysis of patient pancreata suggested a positive role for islet precursors demonstrating significantly superior blood glucose, HbA1c and C-peptide values associated with the transplantation of ductal cells and non-islet PDX-1 and glucagon positive cells.\ud The results of this study indicate that transplantation of non-purified islets can be performed safely and with comparable long-term graft function as purified islets. Additionally, these studies potentially suggest that ductal tissue may help to preserve islet integrity, whilst certain precursors cells found within the acinar parenchyma and ductal epithelium may improve long-term islet graft function

Publisher: University of Leicester
Year: 2011
OAI identifier: oai:lra.le.ac.uk:2381/10071

Suggested articles



  1. A comparative evaluation of culture conditions for short-term maintenance (<24 hr) of human islets isolated using the Edmonton protocol.
  2. (2005). Aberrant acinar cell CA 19-9 expression and peri-insular acinar cell alterations in an adult human pancreas. Virchows Arch
  3. (1982). Abnormal liver function tests as biological markers for alcoholism in narcotic addicts.
  4. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood
  5. (2000). Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes
  6. (2010). Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia
  7. (1995). Advanced protein glycosylation in diabetes and aging. Annu Rev Med
  8. Advances in long-term islet culture: the memphis experience.
  9. (2006). Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes
  10. (1997). Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30-50 years.
  11. (1989). Allotransplantation of culture-isolated neonatal rat islet tissue. Absence of MHC class II positive antigen-presenting cells in nonimmunogenic islets. Diabetes
  12. (2003). Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes
  13. (2005). American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care
  14. (2003). An evaluation of endogenous pancreatic enzyme levels following enzymatic digestion. Transplant Proc
  15. (2002). Analysis and optimization of nutritional set-up for murine pancreatic acinar cells. JOP
  16. (2003). Anatomy and Function of the Exocrine and Endocrine Pancreas. Pathology of the Pancreas, Gallbladder, Extrahepatic Biliary Tracy and Ampullary Region. 198 Maddison Avenue,
  17. (2003). and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis.
  18. (1989). Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes
  19. (2005). Are there any stem cells in the pancreas? Pancreas
  20. (1998). Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant
  21. (2005). Association between endocrine pancreas and ductal system. More than an epiphenomenon of endocrine differentiation and development? J Histochem Cytochem
  22. (2008). Association. Diagnosis and classification of diabetes mellitus. Diabetes Care
  23. (1989). Automated islet isolation from human pancreas. Diabetes
  24. (1988). Automated method for isolation of human pancreatic islets. Diabetes
  25. (2003). Benefits and risks of solitary islet transplantation for type 1 diabetes using steroidsparing immunosuppression: the National Institutes of Health experience. Diabetes Care
  26. (1994). Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas.
  27. (2002). Beta-Cell Neogenesis during Prolonged Hyperglycemia in Rats. Diabetes
  28. (1996). Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells.
  29. (1984). Binding of somatostatin to pancreatic acinar cells.
  30. (2004). Biological activity of pig islet-cell reactive IgG antibodies in xenotransplanted diabetic patients. Xenotransplantation
  31. (2000). Cell loss in isolated human islets occurs by apoptosis. Pancreas
  32. (1992). Cellular composition of islet cell suspensions for transplantation. Transplant Proc
  33. Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia.
  34. (1971). Cephalic phase of insulin secretion in obese adolescents. Diabetes
  35. (2003). Changes in liver enzymes after clinical islet transplantation. Transplantation
  36. (2006). Characterisation of collagen VI within the islet-exocrine interface of the human pancreas: implications for clinical islet isolation? Transplantation
  37. (2003). Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes
  38. (2008). Characterization of pancreatic ductal cells in human islet preparations. Lab Invest
  39. (1994). Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release. Peptides
  40. (2008). Chemical immunosuppression in islet transplantation--friend or foe?
  41. (1994). Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma. Gut
  42. (2006). Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg
  43. (2006). Chronic Pancreatitis: The initial damage and resulting fibrosis patterns.
  44. (1995). Chronic pancreatitis.
  45. (2001). Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes
  46. (1986). Close association of centroacinar/ductular and insular cells in the rat pancreas. Histol Histopathol
  47. (2009). Collaborative Islet Transplant Registry. Collaborative Islet Transplant Registry 6th Annual Report.
  48. (2008). Collaborative Islet Transplant Registry. Collaborative Islet Transplant Registry Fifth Annual Report.
  49. (2008). Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance.
  50. (2005). Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation.
  51. Composition of human islet cell preparations for transplantation.
  52. (1990). Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes
  53. (1999). Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes
  54. (2010). Correlation of pancreatic histopathologic findings and islet yield in children with chronic pancreatitis undergoing total pancreatectomy and islet autotransplantation. Pancreas
  55. (1996). Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology
  56. (1999). Cultures of human liver cells in simulated microgravity environment. Adv Space Res
  57. (1995). Decreased chronic failure of intraperitoneal impure islets versus intrahepatic pure islets in a canine autograft model. Transplant Proc
  58. (2002). Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes
  59. (1984). Degradation of zymogen granules by lysosomes in cultured pancreatic explants.
  60. (1995). Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
  61. (1999). Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter. Endocrinology
  62. (1991). Diabetes mellitus decreases the activity of the albumin promoter in vitro.
  63. (1993). Diabetes mellitus secondary to chronic pancreatitis. Dan Med Bull
  64. (1962). Diabetes mellitus: a &quot;thrifty&quot; genotype rendered detrimental by &quot;progress&quot;?
  65. (1983). Diabetesinduced alterations in liver protein synthesis. Changes in the relative abundance of mRNAs for albumin and other plasma proteins.
  66. (2006). Diabetic microvascular complications--can the presence of one predict the development of another?
  67. (2003). Differentiation and proliferation of endocrine cells in the regenerating rat pancreas after 90% pancreatectomy. Arch Histol Cytol
  68. (1997). Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15.
  69. (1997). Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology
  70. (1994). DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology
  71. (2002). Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development
  72. (2001). Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev
  73. (1991). Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters.
  74. (1986). Does the purity of intraportal islet isografts affect their endocrine function? J Surg Res
  75. (1995). Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia
  76. (2005). Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty. Mayo Clin Proc
  77. (2007). Effect of aging on insulin secretory function and expression of beta cell function-related genes of islets. Diabetes Res Clin Pract
  78. (1998). Effect of embolization of impure islets on liver histology and biochemical variables. Transplant Proc
  79. (1993). Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes
  80. (2004). Effects of C-peptide on microvascular blood flow and blood hemorheology. Exp Diabesity Res
  81. (1989). Effects of islet hormones on amylase secretion and localization of somatostatin binding sites.
  82. (1977). Effects of partial surgical pancreatectomy in rats. I. Pancreatic regeneration. Gastroenterology
  83. (2004). Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation
  84. (2004). Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes
  85. Endocrine and intermediate cells in pancreatic ductal carcinoma and in chronic pancreatitis.
  86. (2005). Endocrine pancreatic tissue plasticity in obese humans is associated with cytoplasmic expression of PBX-1 in pancreatic ductal cells.
  87. (1994). Endocrine tissue associated with the pancreatic ductal system: a light and electron microscopic study of the adult rat pancreas with special reference to a new endocrine arrangement. Anat Rec
  88. (2004). Endothelial cell interactions initiate dorsal pancreas development by selectively inducing the transcription factor Ptf1a. Development
  89. (2001). Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes
  90. Epithelial stem cells in vivo.
  91. (2006). Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterol Clin Biol
  92. (2002). Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors.
  93. (1988). Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule.
  94. (2000). Exocrine contamination of isolated islets of Langerhans deteriorates the process of revascularization after free transplantation. Transplantation
  95. (1999). Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology
  96. (1995). Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development
  97. (2005). Expression of stem cell markers and transcription factors during the remodeling of the rat pancreas after duct ligation. Virchows Arch
  98. (2008). Expression of the &quot;stem cell marker&quot; CD133 in pancreas and pancreatic ductal adenocarcinomas.
  99. (2004). Expression of the intermediate filament vimentin in proliferating duct cells as a marker of pancreatic precursor cells. Pancreas
  100. (1998). Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia
  101. (2002). Factors affecting human islet of Langerhans isolation yields. Transplant Proc
  102. (2009). Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia
  103. (1997). Fatal disseminated intravascular coagulation after autologous islet transplantation. Hum Pathol
  104. (1998). Fernandez-Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology
  105. (2005). Fiveyear follow-up after clinical islet transplantation. Diabetes
  106. (2003). Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors. Diabetologia
  107. (1996). Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology
  108. (1994). Free intraperitoneal islet autografts in pancreatectomized dogs--impact of islet purity and posttransplantation exogenous insulin. Surgery
  109. (1997). Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes
  110. (1995). Functional studies of rat, porcine, and human pancreatic islets cultured in ten commercially available media. Transplantation
  111. (2001). Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation
  112. Growth restriction and exendin 4 promote endocrine expression in cultured islet cells derived from patients with persistent hyperinsulinemic hypoglycemia of infancy (PHHI).
  113. (2005). Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation.
  114. (1997). Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol Cell Biol
  115. HLA and insulin gene associations with IDDM.
  116. (2004). Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. Diabetes
  117. (2001). Human pancreatic ductal cells: large-scale isolation and expansion. Cell Transplant
  118. (2007). Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology
  119. (1995). Identification of rat pancreatic duct cells by their expression of cytokeratins 7, 19, and 20 in vivo and after isolation and culture.
  120. (2005). Immunohistochemical analysis of cytokeratin 7 expression in resting and proliferating biliary structures of rat liver. Hepatology
  121. (2007). Immunohistochemical evidence that culture in the high aspect rotating vessel can up-regulate hormone expression in growth dedifferentiated PHHI-derived islet cells.
  122. (1986). Immunological characteristics of purified pancreatic islet grafts. Transplantation
  123. (2001). Impact of pancreatic head resection on direct medical costs in patients with chronic pancreatitis. Ann Surg
  124. (2010). Implication of Pancreatic Image Findings in Total Pancreatectomy With Islet Autotransplantation for Chronic Pancreatitis. Pancreas
  125. (1994). Improved functional survival of human islets of Langerhans in three-dimensional matrix culture. Cell Transplant
  126. (1999). Improved recovery of cryopreserved canine islets by use of beraprost sodium. Pancreas
  127. (2005). Improved retention of zymogen granules in cultured murine pancreatic acinar cells and induction of acinar-ductal transdifferentiation in vitro. Pancreas
  128. (1995). In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology
  129. (2000). In vitro cultivation of human islets from expanded ductal tissue.
  130. (2005). In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia
  131. (2005). In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mech Dev
  132. (2007). In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology
  133. (2001). In-vitro differentiation of pancreatic beta-cells. Differentiation
  134. (1995). Inclusion of peripancreatic lymph node cells prevents recurrent autoimmune destruction of islet transplants: evidence of donor chimerism. Surgery
  135. (1994). Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis.
  136. (2002). Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation
  137. (1999). Induction of three-dimensional assembly of human liver cells by simulated microgravity.
  138. (2010). Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects. Curr Diab Rep
  139. (1981). Infant of the diabetic mother: review of 225 cases. Obstet Gynecol
  140. (1999). Influence of cell number on the characteristics and synchrony of Ca2+ oscillations in clusters of mouse pancreatic islet cells.
  141. (2002). Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes
  142. (1999). Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science
  143. (1993). Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet
  144. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
  145. Intermediate cells in chronic pancreatitis--ultrastructural observations. Rocz Akad Med Bialymst 1997;42 Suppl
  146. Intermediate cells in the rat pancreas after chronic exposure to lead. Rocz Akad Med Bialymst 1997;42 Suppl
  147. (1972). Intermediate cells of the pancreas. I. Ultrastructural characterization.
  148. (1997). Intermediate endocrine-acinar pancreatic cells in duct ligation conditions.
  149. (1999). Internation Islet Transplant Registry report. Giessen
  150. (2006). International trial of the Edmonton protocol for islet transplantation.
  151. (1998). Intraportal human islet autotransplantation: an immunohistochemical study of islets in situ. Transplant Proc
  152. (2008). Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas
  153. (2008). Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation
  154. (2007). Islet autotransplantation restores normal glucose tolerance in a patient with chronic pancreatitis. Diabetes Care
  155. (1992). Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants.
  156. (2004). Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes
  157. (2006). Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation
  158. (1996). Islet morphogenesis and stem cell markers in rat pancreas.
  159. (2003). Islet regeneration during the reversal of autoimmune diabetes
  160. (2008). Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.
  161. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
  162. (1993). Isolated pancreatic islets of the rat: an immunohistochemical and morphometric study. Anat Rec
  163. (2007). Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies. Xenotransplantation
  164. (1993). Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol
  165. (1978). Long-term effect of pH on B-cell function in isolated islets of Langerhans in tissue culture. Diabetologia
  166. (2006). Longterm maintenance of graft function after islet autotransplantation of less than 1000 IEQ/kg. Pancreas
  167. (2002). Low revascularization of experimentally transplanted human pancreatic islets.
  168. (1999). Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship.
  169. Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?
  170. (1967). Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes
  171. (2002). Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Diabetologia
  172. (2002). Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1. Transplantation
  173. (2000). Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia
  174. Modulation of specific beta cell gene (re)expression during in vitro expansion of human pancreatic islet cells.
  175. (2004). Morbidity associated with intraportal islet transplantation. Transplant Proc
  176. (1994). Mouse pancreatic acinar/ductular tissue gives rise to epithelial cultures that are morphologically, biochemically, and functionally indistinguishable from interlobular duct cell cultures.
  177. (2001). Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes
  178. (2007). NAcetylcysteine derivative inhibits procoagulant activity of human islet cells. Diabetologia
  179. (2002). Nestin expression in pancreatic stellate cells and angiogenic endothelial cells. Histochem Cell Biol
  180. (2000). Nestin-expressing cells in the pancreatic islets of Langerhans.
  181. (2010). New stepwise cooling system for short-term porcine islet preservation. Pancreas
  182. (1998). No correlation between in vitro and in vivo function of human islets. Transplant Proc
  183. (2010). of Health Clinical Center (CC). Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression.
  184. (1999). Optimization of culture conditions for the preservation of monkey pancreatic islets in culture. Pancreas
  185. (1983). Organ explant culture of adult Syrian golden hamster pancreas. In Vitro
  186. (2009). Organisation. World Health Organisation Fact Sheet
  187. (1997). Outcome of surgery for chronic pancreatitis.
  188. (2006). p16INK4a induces an age-dependent decline in islet regenerative potential. Nature
  189. (2001). Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann Surg
  190. (2004). Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of
  191. (2003). Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the leicester general hospital. Transplantation
  192. (1999). Pancreatic beta-cellto-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes
  193. (1994). Pancreatic centroacinar cells. The regulator of both exocrine and endocrine function.
  194. (2008). Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes
  195. (2005). Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development
  196. (1999). Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas.
  197. (2002). Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. Diabetes
  198. (1993). Pancreatic islet transplantation: is purification necessary?
  199. (1996). Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.
  200. (2008). Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes. Pancreas
  201. (2002). Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut
  202. (2002). Pancreatic stem cells.
  203. (1977). Pancreatic tissue culture: depletion of exocrine enzymes and purification of islets for transplantation. Transplant Proc
  204. (1992). Pathogenesis of NIDDM. A balanced overview. Diabetes Care
  205. (2007). PDX-1 expression and proliferation of duct epithelial cells after partial pancreatectomy in rats. Hepatobiliary Pancreat Dis Int
  206. (2003). PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes
  207. (2006). Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev
  208. (1970). Plasma insulin levels during imaginary food ingestion under hypnosis. Proc Soc Exp Biol Med
  209. (1982). Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet autotransplantation. Surgery
  210. (1996). Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care
  211. (1987). Predictive value of early pregnancy glycohemoglobin in the insulin-treated diabetic patient.
  212. (2007). Predictors of mortality following symptomatic pulmonary embolism in patients undergoing noncardiac surgery.
  213. (2002). Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med
  214. (2004). Preservation of human pancreatic islet in vivo function after 6-month culture in serum-free media. Transplantation
  215. (1992). Preserved insulin secretion and insulin independence in recipients of islet autografts.
  216. (2005). Pretransplant islet culture: a comparison of four serum-free media using a murine model of islet transplantation. Transplant Proc
  217. (2009). Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas
  218. (2001). Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes
  219. (2002). Primary culture of porcine pancreatic acinar cells. Pancreas
  220. (1998). Protein kinase C activation and the development of diabetic complications. Diabetes
  221. (1990). Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site. Transplantation
  222. (1985). Racial differences in incidence of juvenileonset type 1 diabetes: epidemiologic studies in southern California. Diabetologia
  223. (2009). Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology
  224. (2004). Regeneration of betacells and neogenesis from small ducts or acinar cells promote recovery of endocrine pancreatic function in alloxan-treated rats. Arch Med Res
  225. (1999). Regional differences in the cellular proliferation activity of the regenerating rat pancreas after partial pancreatectomy. Arch Histol Cytol
  226. (1997). Repeated intraportal injections of subtherapeutic islet cell isografts restore normoglycemia in streptozotocin-diabetic rats. Cell Transplant
  227. (2005). Rescue purification maximizes the use of human islet preparations for transplantation.
  228. (2004). Risks and side effects of islet transplantation. Curr Diab Rep
  229. (2000). Role of C-peptide in human physiology.
  230. Seven consecutive successful clinical islet isolations with pancreatic ductal injection.
  231. (1994). Significance of contaminated islet preparations in clinical islet transplantation. Transplant Proc
  232. (2006). Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes
  233. Somatostatin analogues and exocrine pancreatic secretion.
  234. (1986). Somatostatin receptors on rat pancreatic acinar cells. Pharmacological and structural characterization and demonstration of downregulation in streptozotocin diabetes.
  235. (1999). Splenic infarction after total pancreatectomy and autologous islet transplantation into the spleen. Pancreas
  236. (1999). Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery
  237. (2006). Suitability of human juvenile pancreatic islets for clinical use. Diabetologia
  238. (2004). Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors.
  239. (2007). Support Team. Diabetes in the NHS: commissioning and providing specialist services.
  240. (2003). Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA
  241. (2009). Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system. Diabetologia
  242. (2005). Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cellderived insulin-producing cells.
  243. (2008). The barrier of hypoglycemia in diabetes. Diabetes
  244. (2005). The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care
  245. (1999). The canals of Hering and hepatic stem cells in humans. Hepatology
  246. (2004). The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation
  247. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
  248. (1993). The effect of prednisone on pancreatic islet autografts in dogs. Surgery
  249. (1978). The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies. Virchows Arch A Pathol Anat Histol
  250. (2003). The expression of pancreatic endocrine markers in centroacinar cells of the normal and regenerating rat pancreas: their possible transformation to endocrine cells. Arch Histol Cytol
  251. The isolation and function of porcine islets from market weight pigs.
  252. (1989). The role of exocrine tissue in pancreatic islet transplantation. Transpl Int
  253. (2001). The role of newer monoclonal antibodies in renal transplantation. Transplant Proc
  254. The role of the innate immunity in islet transplantation.
  255. (2002). The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet
  256. (2007). The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am
  257. (1999). The structural integrity of the islet in vitro: the effect of incubation temperature. Pancreas
  258. (1993). The use of continuous density gradients for the assessment of islet and exocrine tissue densities and islet purification.
  259. (1985). Time course of changes in albumin synthesis and mRNA in diabetic and insulin-treated diabetic rats.
  260. (1977). Tissue culture isolation and preservation of human cadaveric pancreatic islets. Surgery
  261. (2005). Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes
  262. (1988). Total pancreatectomy for chronic pancreatitis. Gut
  263. (2008). Total Pancreatectomy With and Without Islet Cell Transplantation for Chronic Pancreatitis: A Series of 85 Consecutive Patients. Pancreas
  264. (2005). Transaminitis after pancreatic islet transplantation.
  265. (2008). Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans
  266. (2004). Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis.
  267. (2001). Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet
  268. (2010). Type 2 diabetes mellitus in children and adolescents. Adolesc Med State Art Rev
  269. (2001). University of wisconsin solution with trypsin inhibitor pefabloc improves survival of viable human and primate impure islets during storage. Cell Tissue Bank
  270. Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation.
  271. (2008). Viral infections in the pathogenesis of autoimmune diseases: focus on type 1 diabetes. Front Biosci

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.